Abstract
Recent genome-wide association (GWA) studies described 95 loci controlling serum lipid levels. These common variants explain ∼25% of the heritability of the phenotypes. To date, no unbiased screen for gene-environment interactions for circulating lipids has been reported. We screened for variants that modify the relationship between known epidemiological risk factors and circulating lipid levels in a meta-analysis of genome-wide association (GWA) data from 18 population-based cohorts with European ancestry (maximum N = 32,225). We collected 8 further cohorts (N = 17,102) for replication, and rs6448771 on 4p15 demonstrated genome-wide significant interaction with waist-to-hip-ratio (WHR) on total cholesterol (TC) with a combined P-value of 4.79×10(-9). There were two potential candidate genes in the region, PCDH7 and CCKAR, with differential expression levels for rs6448771 genotypes in adipose tissue. The effect of WHR on TC was strongest for individuals carrying two copies of G allele, for whom a one standard deviation (sd) difference in WHR corresponds to 0.19 sd difference in TC concentration, while for A allele homozygous the difference was 0.12 sd. Our findings may open up possibilities for targeted intervention strategies for people characterized by specific genomic profiles. However, more refined measures of both body-fat distribution and metabolic measures are needed to understand how their joint dynamics are modified by the newly found locus.
Introduction
Genome-wide association studies (GWAS) have successfully identified nearly 100 genetic markers associated with blood lipid levels, such as LDL and HDL cholesterol. However, these variants collectively explain only about 25% of the estimated heritability for these traits. A significant portion of this "missing heritability" is hypothesized to stem from gene-environment (GxE) interactions—phenomena where the effect of a genetic variant is contingent upon environmental exposures or physical characteristics, such as diet, smoking habits, or obesity.
Historically, GxE research in lipid metabolism has been confined to "candidate gene" studies. These studies often suffer from selection bias and have proven difficult to replicate consistently. To address this gap, this study presents the first systematic, unbiased genome-wide screen to identify variants that modify the relationship between common epidemiological risk factors and lipid profiles.
Methodology
The study employed a robust three-stage meta-analysis design involving a massive international collaboration through the ENGAGE Consortium, encompassing a total of 43,903 individuals of European ancestry.
Discovery Phase (Stage 1)
The discovery screen analyzed 2.5 million genetic markers across 18 population-based cohorts (N = 32,225), including the FINRISK, NFBC1966, and TwinUK studies. The primary objective was to test for interactions between these markers and five established risk factors: sex, smoking status, alcohol consumption, Body Mass Index (BMI), and Waist-to-Hip Ratio (WHR).
Replication and Functional Follow-up
Promising candidates from the discovery phase were subjected to replication in 10 additional independent cohorts (N = 17,102 in Stage 2; N = 7,813 in Stage 3) to ensure statistical robustness. To investigate the biological mechanisms underlying identified interactions, the researchers performed expression quantitative trait loci (eQTL) analysis. This involved examining whether identified single nucleotide polymorphisms (SNPs) influenced the activity of nearby genes in adipose tissue and blood. Adipose eQTL analysis utilized fat biopsies and GWA data from 54 individuals from Finnish dyslipidemic families.
Metabolic Profiling
To refine the phenotypic understanding of the interaction, the team utilized NMR metabonomics. This allowed for a more granular view of lipid profiles, moving beyond "total cholesterol" to examine specific lipoprotein subclasses, such as large HDL or VLDL particles.
Results
The systematic screen identified a novel genetic locus on chromosome 4p15. The lead variant, rs6448771, demonstrated a genome-wide significant interaction with WHR on total cholesterol (TC), yielding a combined P-value of $4.79 \times 10^{-9}$.
Interaction Dynamics
Notably, rs6448771 exhibits no significant "main effect" on cholesterol levels independently. Instead, it acts as a modulator for the impact of abdominal obesity. The effect of WHR on total cholesterol was found to be approximately 64% stronger in individuals with the GG genotype compared to those with the AA genotype. Specifically, a one standard deviation (sd) increase in WHR corresponded to a 0.19 sd increase in TC for GG carriers, versus a 0.12 sd increase for AA carriers.
Biological Context
The SNP is located near two candidate genes: PCDH7 and CCKAR. Functional analysis revealed that the SNP's influence on gene expression was specific to adipose tissue and absent in blood. This suggests that the interaction is mediated through the biology of fat cells. CCKAR (Cholecystokinin A Receptor) is of particular interest due to its known roles in obesity and satiety regulation.
Refined Phenotypes
NMR metabonomics data indicated that the interaction specifically impacts the concentrations of large HDL and large VLDL particles, rather than exerting a uniform effect across all cholesterol fractions.
Discussion
This study represents a significant step forward in understanding the complex genetic architecture of lipid metabolism. By identifying a "context-dependent" SNP, the researchers have highlighted the importance of considering environmental and physical factors in genetic studies.
Challenges in GxE Research
Despite the large sample size, only one locus reached genome-wide significance. This outcome suggests that GxE effects may be individually small or that current methods for measuring "environment" (e.g., self-reported data or simple anthropometric measures like WHR) lack the precision necessary to capture subtle biological interactions.
Future Directions
The identified interaction explains approximately 0.5% of the variance in total cholesterol. Future research will likely require even larger cohorts or "deep phenotyping"—utilizing wearable sensors for physical activity or precise dietary tracking—to uncover further components of the genetic architecture. While PCDH7 and CCKAR are promising candidates, further molecular investigations are required to elucidate the exact pathways through which they modify lipid metabolism in response to body fat distribution. These findings may eventually pave the way for targeted intervention strategies tailored to an individual's specific genomic and metabolic profile.
Summary updated